The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Hims & Hers Health Inc shares valued at $450,730 were sold by Okupe Oluyemi on Feb 04 ’25. At $38.92 per share, Okupe Oluyemi sold 11,581 shares. The insider’s holdings dropped to 112,933 shares worth approximately $4.77 million following the completion of this transaction.
Also, Dudum Andrew sold 100,000 shares, netting a total of over 3,522,300 in proceeds. Following the sale of shares at $35.22 each, the insider now holds 27,918 shares.
Before that, Boughton Soleil had sold 4,153 shares from its account. In a trade valued at $146,601, the Chief Legal Officer traded Hims & Hers Health Inc shares for $35.30 each. Upon closing the transaction, the insider’s holdings decreased to 4,153 shares, worth approximately $6.82 million.
As published in a research note from Citigroup on January 10, 2025, Hims & Hers Health Inc [HIMS] has been rated down from a Neutral to a Sell and the price target has been revised to $25 from $24. Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of December 17, 2024, Morgan Stanley has initiated its “an Overweight” rating for HIMS. Earlier on November 14, 2024, BofA Securities downgraded its rating. Their new recommendation was “an Underperform” for HIMS stock which previously was a “a Buy”.
Analyzing HIMS Stock Performance
During the last five days, there has been a surge of approximately 32.45%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 74.52%. Shares of the company reached a 52-week high of $44.43 on 02/05/25 and a 52-week low of $24.07 on 01/10/25. A 50-day SMA is recorded $29.94, while a 200-day SMA reached $21.42. Nevertheless, trading volume fell to 17.25 million shares from 16.47 million shares the previous day.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 40.92, which, if violated, would cause prices to drop to 39.65. In the upper region, resistance lies at 43.95. The next price resistance is at 45.71. RSI (Relative Strength Index) is 82.77 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 7.76, which suggests the price will increase in the coming days. Percent R is at 11.82%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
